BRIEF-Biospecifics Technologies positive results from phase 2 trial of CCH
June 13, 2016 at 07:48 AM EDT
* Biospecifics technologies corp. Announces positive top-line results from phase 2 trial of cch for treatment of human lipoma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|